10 Best “Strong Buy” Stocks — ICLR HOLX IMKTA and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

Since January 1, ICON Plc (ICLR) has climbed 46.2%. ICON provides contract clinical research services to the global pharmaceutical industry. For more information, get Portfolio Grader’s complete analysis of ICLR stock.

Since January 1, the price of Hologic, Inc. (HOLX) has grown 47.6%. Hologic develops, manufactures, and markets x-ray systems. For more information, get Portfolio Grader’s complete analysis of HOLX stock.

Since January 1, Ingles Markets, Incorporated Class A (IMKTA) has jumped 55.6%. Ingles Markets operates a supermarket chain in the southeastern United States. For more information, get Portfolio Grader’s complete analysis of IMKTA stock.

Shares of Ebix, Inc. (EBIX) have leaped 67.7% since January 1. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

Since the first of the year, the price of Stamps.com (STMP) has swelled 73.3%. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.

The price of Ellie Mae, Inc. (ELLI) has seen an 83.4% boost since the first of the year. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

The price of Sucampo Pharmaceuticals, Inc. Class A (SCMP) is up 85.3% since the first of the year. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.

Skechers U.S.A., Inc. Class A (SKX) has risen 148.8% since the first of the year. Skechers USA designs, makes, markets and distributes footwear. Trade volume has increased significantly over the past week, up 91.3%. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Shares of ABIOMED, Inc. (ABMD) have risen 164.6% since January 1. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Since the first of the year, shares of Chimera Investment Corporation (CIM) have soared 308.8%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock has a trailing PE Ratio of 4.90. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/08/10-best-strong-buy-stocks-iclr-holx-imkta-and-more-iclr-holx-imkta/.

©2021 InvestorPlace Media, LLC